AMN Healthcarervices

Amn Healthcare Services stock rose to a 52-week high of $36.31 and is currently trading at $36.50. Year-to-date the shares have gained about 95%, with a one-year increase of approximately 105.6% and more than 51% in the past six months. In the second quarter the company reported adjusted earnings of $0.77 per share on revenue of $673.2 million, comfortably beating expectations; growth was driven mainly by higher demand for nursing staff, allied health and search services. InvestingPro regards Amn as undervalued with a market capitalization of $1.39 billion, while revenue grew by almost 24% over the past twelve months. » More on de.investing.com

AMN Healthcare reported adjusted earnings of $0.77 per share for Q2 on revenue of $673.2 million, well above consensus expectations of $0.18 and $627.79 million. The performance was driven mainly by the Nurse and Allied Solutions segment, which saw record volumes in travel nurses and allied health, while Physician and Leadership and Technology and Workforce declined. The company said about $27 million of revenue and 290 basis points of gross margin were due to one‑time items. For Q3 AMN forecasts revenue of $640–655 million and an adjusted EBITDA margin of 6.5–7%. The stock rose about 12.4% in after‑hours trading to $34.61. » More on de.investing.com

AMN Healthcare has appointed Eric Palmer to its board of directors effective May 1, 2026. Palmer brings more than 25 years of healthcare experience, most recently as CEO of Evernorth Health Services, and previously served as CFO at Cigna. The appointment comes amid a financial turnaround; the stock is significantly up year-to-date and analysts expect the company to return to profitability this year. AMN provides staffing solutions for healthcare and reports that its clinicians cared for more than 13 million patients in 2025. » More on de.investing.com